These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8304925)

  • 1. Chemoprotection by inducers of electrophile detoxication enzymes.
    Kensler TW; Davidson NE; Groopman JD; Roebuck BD; Prochaska HJ; Talalay P
    Basic Life Sci; 1993; 61():127-36. PubMed ID: 8304925
    [No Abstract]   [Full Text] [Related]  

  • 2. Detoxication enzymes and chemoprevention.
    Wilkinson J; Clapper ML
    Proc Soc Exp Biol Med; 1997 Nov; 216(2):192-200. PubMed ID: 9349688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of rat glutamate-cysteine ligase (gamma-glutamylcysteine synthetase) subunits by chemopreventive agents and in aflatoxin B(1)-induced preneoplasia.
    Shepherd AG; Manson MM; Ball HW; McLellan LI
    Carcinogenesis; 2000 Oct; 21(10):1827-34. PubMed ID: 11023540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
    Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD
    Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intragastrically administered Pycnogenol on NNK metabolism in F344 rats.
    Huynh HT; Teel RW
    Anticancer Res; 1999; 19(3A):2095-9. PubMed ID: 10470154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprotection against cancer by phase 2 enzyme induction.
    Talalay P; Fahey JW; Holtzclaw WD; Prestera T; Zhang Y
    Toxicol Lett; 1995 Dec; 82-83():173-9. PubMed ID: 8597048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potency of Semecarpus anacardium Linn. nut milk extract against aflatoxin B(1)-induced hepatocarcinogenesis: reflection on microsomal biotransformation enzymes.
    Premalatha B; Sachdanandam P
    Pharmacol Res; 2000 Aug; 42(2):161-6. PubMed ID: 10887046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-carotene prevents lipid peroxidation and red blood cell membrane protein damage in experimental hepatocarcinogenesis.
    Sarkar A; Bishayee A; Chatterjee M
    Cancer Biochem Biophys; 1995 Nov; 15(2):111-25. PubMed ID: 8590436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer chemoprotection by oltipraz: experimental and clinical considerations.
    Helzlsouer KJ; Kensler TW
    Prev Med; 1993 Sep; 22(5):783-95. PubMed ID: 8234218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of caffeic acid phenethyl ester analogues in a modified resistant hepatocyte model.
    Macías-Pérez JR; Beltrán-Ramírez O; Vásquez-Garzón VR; Salcido-Neyoy ME; Martínez-Soriano PA; Ruiz-Sánchez MB; Angeles E; Villa-Treviño S
    Anticancer Drugs; 2013 Apr; 24(4):394-405. PubMed ID: 23388162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The light at the end of the tunnel for chemical-specific biomarkers: daylight or headlight?
    Groopman JD; Kensler TW
    Carcinogenesis; 1999 Jan; 20(1):1-11. PubMed ID: 9934843
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of antioxidants on aflatoxin-induced hepatic tumors in rats.
    Iverson F; Campbell J; Clayson D; Hierlihy S; Labossiere E; Hayward S
    Cancer Lett; 1987 Feb; 34(2):139-44. PubMed ID: 3102038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenium in cancer prevention: clinical issues and implications.
    Raich PC; Lü J; Thompson HJ; Combs GF
    Cancer Invest; 2001; 19(5):540-53. PubMed ID: 11458820
    [No Abstract]   [Full Text] [Related]  

  • 14. Carcinogen-DNA and protein adducts as intermediate biomarkers for human chemoprotection trials.
    Groopman JD; Roebuck BD; Kensler TW
    Adv Exp Med Biol; 1994; 354():149-60. PubMed ID: 8067283
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection against cancer by plant phenylpropenoids: induction of mammalian anticarcinogenic enzymes.
    Dinkova-Kostova AT
    Mini Rev Med Chem; 2002 Dec; 2(6):595-610. PubMed ID: 12370043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Special issue: Selenium and cancer: Larry C. Clark memorial issue.
    Nutr Cancer; 2001; 40(1):1-77. PubMed ID: 12214566
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Beta-carotene: a miss for epidemiology.
    Brignall M; Lamson D
    J Natl Cancer Inst; 2000 Jun; 92(12):1014; author reply 1016. PubMed ID: 10861316
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer chemoprevention: some complications and limitations.
    Paolini M; Mesirca R; Pozzetti L; Gialluca N; Bauer C; Biagi GL; Cantelli-Forti G
    Cancer Detect Prev; 1998; 22(1):68-74. PubMed ID: 9466052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
    Hirose M; Hasegawa R; Kimura J; Akagi K; Yoshida Y; Tanaka H; Miki T; Satoh T; Wakabayashi K; Ito N
    Carcinogenesis; 1995 Dec; 16(12):3049-55. PubMed ID: 8603484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considering the mechanisms of cancer prevention by selenium.
    Combs GF
    Adv Exp Med Biol; 2001; 492():107-17. PubMed ID: 11480659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.